genomic insights are increasingly becoming a cornerstone in the management of Chronic Lymphocytic Leukaemia (CLL), offering a more targeted and personalized approach to treatment. Genomic profiling has revealed a…
sequencing has been the constrain driving numerous later propels in Chronic lymphocytic leukemia (CLL) investigate. Here, we talk about the common standards, disclosures, and applications of perusing the BCR immune…
confirmed by bone marrow (BM) biopsy. BM biopsy revealed Chronic lymphocytic leukemia (CLL) with normal megakaryocytes consistent with concomitant ITP, a combination seen in only 1–5% cases of CLL ... chemotherapy…
Background:The most frequent cytogenetic aberration is 13q14.3 deletion in Chronic Lymphocytic Leukemia (CLL). Hsa-miR-15a/hsa-miR-16-1 are tumor suppressor miRNAs encoded from 13q14.3 region. Objectives…
Antibody therapies for treating chronic lymphocytic leukemia (CLL) remain a challenge for many CLL patients who are insensitive to antibody treatment. A high percentage of CLL patients that are resistant ... Many…
Antibody therapies for treating chronic lymphocytic leukaemia (CLL) remain a challenge for many CLL patients who are insensitive to antibody treatment. A high percentage of CLL patients that are resistant ... Many…
cancers, including diff use large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia (CLL), we developed in collaboration with Clark W Distelhorst (Case Western Reserve University, USA) BIRD ... increasing IP3…
analysis demonstrated that blasts were associated with co-expression of Chronic Lymphocytic Leukemia (CLL) and Acute Myeloid Leukemia (AML) immunophenotyping. In the third case Bone Marrow Biopsy (BMB) showed…
aggressive lymphoma and at times can share many features with chronic lymphocytic leukemia (CLL). CLL is positive for CD5+ (in 80% of cases), CD20+ (95%) and CD23 ... aware of the less commonly used tests to help…
Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy that has a highly variable clinical course. Genomic features as zeta-chain-associated protein kinase 70 (ZAP70) expressions and CD38 expression…
Background/Aims: The expression of chemokines is altered in chronic lymphocytic leukemia (CLL) due to inactivation of the tumour suppressor genes or constitutive activation of the oncogenes ... measure plasma levels of…
patients were including 22 diffuse large B-cell lymphoma (DLBCL), 15 chronic lymphocytic leukemia (CLL), 9 follicular lymphoma patients (FL) and 7 subjects with burkitt′s lymphoma (BL). The samples ... discriminating…
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and is still considered an incurable disease because most patients generally relapse and eventually develop drug-resistance ... barrier…
Purpose: Treatment options for patients with previously-treated Chronic Lymphocytic Leukemia (CLL) are limited; no standard of care exists. In the Phase III RESONATE trial, oral, once-a-day, first ... effectiveness of…
Kidney damage in non-Hodgkin lymphoma/leukemia (NHL/CLL) and lymphoplasmacytic lymphomas (LPCL) are caused by several mechanisms: tumor mass localization; clonal cell expansion; hormones, cytokines and growth factors…
immunophenotypic findings is essential for prognosis and therapeutic targeting of Chronic Lymphocytic Leukemia (CLL). Hyperleukocytosis (absolute leukocyte count exceeding 100,000 cells/mm3) in CLL has been clinically…
Chronic lymphocytic leukemia (CLL) is a malignant proliferation of mature, differentiated B-lymphocytes, frequently associated with autoimmune hemolytic anemia (AIHA). The effect of this complication in the clinical…
Chronic Lymphocytic Leukemia (CLL) is a B-cell malignant disease characterized by a progressive accumulation of B cells in the blood, bone marrow and lymphatic tissue, and which follows ... extended disease course [1]…
cell receptor (BCR) signaling in B-cell from lymphomas such as Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL) and the emergence of new drugs targeting BCR signaling molecules ... promising therapeutic…
CLL is presently an incurable disease representing the most common form of leukemia in North America and Europe. Unlike other cancer cells which are inherently driven by uncontrolled proliferation, CLL ... inhibitors…
Chronic Lymphocytic Leukemia (CLL) is characterized by presence of abnormal monoclonal lymphocytes, circulating in blood that may infiltrate all organs, particularly those of lymphoreticular system. This disorder has a…
patients of Acute B-lymphocytic Leukemia (ALL), five patients of Chronic B-lymphocytic Leukemia (CLL), and four healthy control blood donors. Mean percentage of B cells in PBMC samples ... healthy controls), 56.50%…
Introduction: Some diagnosed cases of chronic lymphocytic leukaemia (CLL) with possible mutations of the p-53 gene in the human B lymphocyte genome were investigated in this study. Method: Using ... ELISA technique, the…
Chronic lymphocytic leukemia (CLL) is an environment-dependent hematologic malignancy where interactions with accessory cells through cytokines and their receptors seem to confer a survival advantage, thus contributing…
Background: Chronic lymphocytic leukemia (CLL) is one of the chronic lymphoproliferative disorders. Many drugs were used for treatment of CLL, but efficacy of them is controversy. In present study ... compare survival…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.